Search

everythinglearnresearchcommunity

for

Search:↓

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Nilotinib may cause gray hair to return to its original color.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Rituximab may cause skin issues, but baricitinib can help improve them.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.